Product Overview
Letrobol Tablets hold 2.5 mg of letrozole, the reversible non-steroidal inhibitor that heads the type II group in terms of raw strength. The tablets are produced and packed under GMP conditions with the active mass stated, and the 2.5 mg unit is the medical-grade dose rather than a convenient sports one. That single fact shapes everything on this page: the practical on-cycle amount is a fraction of a tablet, and the most common mistake with this product is treating it like its weaker cousins.
The target is the same cytochrome P450 aromatase enzyme that a reversible competitor and a steroidal irreversible one act on, and the result is a fall in circulating estradiol rather than a block at the receptor. Pharmacodynamic work cited in the fact sheet shows 2.5 mg a day holding aromatase down by about 98.9 to 99.1 percent. Numbers that close to complete are why this product is normally held in reserve for a cycle where water and breast sensitivity are not responding to a gentler inhibitor, rather than opened on day one of a testosterone ester cycle.
Where a receptor-level drug such as Tamoxifen Tablets is used once sensitivity has already appeared, letrozole belongs to the stage before that, when production still needs to be brought under control quickly and decisively. The price is a narrow margin: the gap between useful and excessive is small, and it is measured in quarter-tablets.
Dosage Protocol
The table follows the project fact sheet. Amounts are low because the compound is strong, and laboratory values rather than symptoms decide any move.
| Beginner | 0.25-0.625 mg every second day, which is a quarter or a half of a tablet, across 4-6 weeks with testing |
| Intermediate | 0.625-1.25 mg every second day across 6-8 weeks; the amount is chosen from the estradiol level rather than from a diary |
| Advanced | 1.25-2.5 mg daily, the top of the range corresponding to the medical 2.5 mg daily dose, where dry joints and a flat libido become likely |
| Female | The 2.5 mg daily figure is a medical dose used for ovulation induction in polycystic ovary syndrome under supervision; it is not a sports protocol and none is confirmed here |
| Administration | Oral at a consistent time; the tablet is divided into quarters for the lower steps and the roughly two-day elimination supports an alternate-day rhythm |
Suggested Protocols
Three ways this product is actually used. In each one it appears as the strong arm of the plan, added to or replacing a milder inhibitor.
What to Expect
The onset is fast and the consequences of overshooting are the main thing to watch, because the response is steep.
- First few days. Puffiness and breast sensitivity begin to settle, and the change can be noticeably quicker and blunter than with a milder inhibitor.
- Full effect. At 2.5 mg daily the enzyme is held down by the high nineties in percentage terms, so the reached level can be stronger than intended and stronger than needed.
- Dry joints and a flat libido. The typical complaints of over-drying, and the fact sheet notes they are reported more often than with anastrozole.
- Testing. An estradiol value ahead of the start and while on the drug is the sole dependable way to stay out of a low-estrogen state; guessing on a compound this strong rarely works.
- Limit. A whole tablet every day is almost always more than a sports protocol needs, which is why the practical amounts are written as fractions.
- Limit two. Prolonged use is associated with a bone-density concern, so open-ended months of dosing are not justified.
- Limit three. It is not a product for women outside a medical indication.
Side Effects and Management
Because the compound is potent, most entries here appear as soon as the amount is a shade too high, and they ease when it comes down.
Reserve Role and Follow-Up
Letrozole does not switch off the gonadal axis, so the question is not when to start a recovery protocol but when to retire the inhibitor.
